These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 946555)

  • 1. [A comparative assessment of the efficacy of antithyroid therapy in patients with nodular and diffuse toxic goiter].
    Alesov VZ
    Probl Endokrinol (Mosk); 1976; 22(1):12-5. PubMed ID: 946555
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dynamics of PBI behavior in blood serum of patients with Graves-Basedow disease and toxic nodular goiter during treatment with methimetazole].
    Jaruga-Dolińska E; Zembrzuska Z; Korman E
    Endokrynol Pol; 1971; 22(6):535-43. PubMed ID: 4110630
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
    Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
    Horm Res; 2008; 70(3):155-64. PubMed ID: 18663316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neck thermography in the differentiation between diffuse toxic goiter during methimazole treatment and normal thyroid.
    Rossato M; Burei M; Vettor R
    Endocrine; 2015 Apr; 48(3):1016-7. PubMed ID: 24898902
    [No Abstract]   [Full Text] [Related]  

  • 5. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
    Berg GE; Michanek AM; Holmberg EC; Fink M
    J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Goiter size and prognosis of thyrotoxicosis treated medically].
    Laurberg P; Hansen PE; Iversen E; Jensen SE; Weeke J
    Ugeskr Laeger; 1987 May; 149(20):1325-7. PubMed ID: 3603777
    [No Abstract]   [Full Text] [Related]  

  • 7. [Radioisotope methods of control of the effectiveness of treatment of diffuse toxic goiter with mercazolyl].
    Egorenkov AN
    Med Radiol (Mosk); 1976; 21(9):47-53. PubMed ID: 1036752
    [No Abstract]   [Full Text] [Related]  

  • 8. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
    Gedik O; Ozdemir T; Akalin S
    Isr J Med Sci; 1991 Jul; 27(7):361-4. PubMed ID: 1712765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
    Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthyroidism.
    Zellmann HE
    Med Clin North Am; 1972 May; 56(3):717-24. PubMed ID: 5067818
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lithium acetate, a useful and well tolerated thyrostatic for selected cases of hyperthyroidism].
    Eigenmann F; Bürgi H
    Schweiz Med Wochenschr; 1978 Nov; 108(47):1850-3. PubMed ID: 581407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of toxic multinodular goiter].
    Fagel WJ; van der Vijver JC
    Ned Tijdschr Geneeskd; 1987 Feb; 131(6):252-3. PubMed ID: 2436063
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative curative effect of Mercasolyl and potassium perchlorate in treating patients with diffuse toxic goiter].
    Anvarova ShS
    Sov Med; 1972 Jul; 35(7):84-8. PubMed ID: 4115205
    [No Abstract]   [Full Text] [Related]  

  • 14. [Normalization of the functional regulation of the thyroid as a criterion of the remission of diffuse toxic goiter following antithyroid treatment].
    Khelds AO
    Probl Endokrinol (Mosk); 1986; 32(4):11-4. PubMed ID: 2429297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
    Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ¹³¹I treatment of toxic nodular goiter under combined thyrostatic-thyromimetic medication is at low risk of late hypothyroidism.
    Paghera B; Panarotto MB; Maira G; Magri GC; Bertagna F; Bosio G; Rossini P; De Agostini A; Savelli G; Lucchini S; Giubbini R
    Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):341-7. PubMed ID: 20639819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial evaluating a block-replacement regimen during radioiodine therapy.
    Bonnema SJ; Grupe P; Boel-Jørgensen H; Brix TH; Hegedüs L
    Eur J Clin Invest; 2011 Jul; 41(7):693-702. PubMed ID: 21175612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.
    Pedro AB; Romaldini JH; Takei K
    Neuroimmunomodulation; 2011; 18(1):45-51. PubMed ID: 20628263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience using lithium carbonate in the complex treatment of diffuse toxic goiter].
    Petrov NM
    Ter Arkh; 1985; 57(12):32-6. PubMed ID: 3937256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum IL-16 and RANTES levels in patients with autoimmune thyroid diseases and modulation by methimazole therapy.
    Gu X; Zheng L; Chen X; Ruan L; Zhang H; Ge S; Zhu H; Lin X; Shen F
    Horm Metab Res; 2012 Jun; 44(6):482-7. PubMed ID: 22473756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.